The amount of antibodies produced by the Sinovac vaccine and the BioNTech vaccine in Hong Kong was examined. According to the research, BioNTech produces 10 times more antibodies than Sinovac. Experts believe that placing emphasis on mRNA vaccines will make it easier to overcome the epidemic.
The medical journal The Lancet has published the results of the latest research on coronavirus vaccines. According to the article, the antibody levels created by the mRNA-based BioNTech vaccine, which is also used in Turkey, and the passive virus-based Sinovac vaccine, were determined. According to research, BioNTech creates 10 times more antibodies than Sinovac.
The study investigating the amount of antibody formation in coronavirus vaccines was carried out in Hong Kong. By measuring the amount of antibodies in the bodies of people who had vaccinated in the area, the scientists found an average ratio between the two vaccines. Here the ratio of 10 reveals that mRNA vaccines are more effective than traditional vaccines.
According to a report in Bloomberg, there is a serious decrease in the rate of spread of the disease in countries such as the USA and Israel, which implement mRNA-based vaccines. However, this does not mean that the coronavirus vaccine produced by Sinovac is not good enough. Examining the situation in countries using Sinovac, Bloomberg concluded that the death and severe illness rates in these countries were significantly reduced.
Speaking of vaccines, coronavirus vaccine applications in Turkey continue at full speed. When we look at the website of the Ministry of Health regarding the amount of coronavirus vaccination, we see that more than 61 million doses have been made to date. Of these, 19.2 million were second doses. Although this figure looks good, it should at least double as soon as possible. Because the vaccines that will allow us to get rid of the scourge of coronavirus show the main effect after the second dose.